| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.55B | +1.9% |
| Cost of Revenue | $445.1M | -7.0% |
| Gross Profit | $2.10B | +4.0% |
| R&D Expense | $914.9M | -2.3% |
| SG&A Expense | $241.2M | +1.7% |
| Operating Income | $486.2M | -9.7% |
| Pre-tax Income | $509.8M | -8.0% |
| Income Tax | $57.5M | -43.0% |
| Net Income | $452.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.33B | +116.0% |
| Accounts Receivable | $70.4M | +2.5% |
| Current Assets | $1.74B | +14.6% |
| Total Assets | $3.33B | +11.5% |
| Current Liabilities | $1.21B | +0.8% |
| Total Liabilities | $4.08B | +29.5% |
| Stockholders' Equity | -$752.4M | -353.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $894.1M | +14.1% |
| Capital Expenditures | $22.5M | -7.4% |
| Investing Cash Flow | $443.8M | +12.3% |
| Financing Cash Flow | -$586.6M | +26.6% |
| Free Cash Flow | $871.6M | +14.8% |
| -0.3% |
| EPS (Basic) | $1.42 | +6.8% |
| EPS (Diluted) | $1.40 | +6.9% |